MDI, Launch Diagnostics Distributing MRSA Test | GenomeWeb

a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — Molecular Detection and Launch Diagnostics today announced an exclusive distribution agreement for MDI's real-time PCR-based diagnostic for methicillin-resistant Staphylococcus aureus.

The agreement covers the UK, France, and Republic of Ireland. Other terms of the agreement were not disclosed.

The two firms also announced that the test, called Detect-Ready MRSA, has been launched in the UK and the Republic of Ireland.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.